Targeting anti-chondrogenic factors for the stimulation of chondrogenesis

A new paradigm in cartilage repair

Andrea Lolli, Fabio Colella, Cosimo De Bari, Gerjo J V M van Osch (Corresponding Author)

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

Trauma and age-related cartilage disorders represent a major global cause of morbidity, resulting in chronic pain and disability in patients. A lack of effective therapies, together with a rapidly aging population, creates an impressive clinical and economic burden on healthcare systems. In this scenario, experimental therapies based on transplantation or in situ stimulation of skeletal Mesenchymal Stem/progenitor Cells (MSCs) have raised great interest for cartilage repair. Nevertheless, the challenge of guiding MSC differentiation and preventing cartilage hypertrophy and calcification still needs to be overcome. While research has mostly focused on the stimulation of cartilage anabolism using growth factors, several issues remain unresolved prompting the field to search for novel solutions. Recently, inhibition of anti-chondrogenic regulators has emerged as an intriguing opportunity. Anti-chondrogenic regulators include extracellular proteins as well as intracellular transcription factors and microRNAs that act as potent inhibitors of pro-chondrogenic signals. Suppression of these inhibitors can enhance MSC chondrogenesis and production of cartilage matrix. We here review the current knowledge concerning different types of anti-chondrogenic regulators. We aim to highlight novel therapeutic targets for cartilage repair and discuss suitable tools for suppressing their anti-chondrogenic functions. Further effort is needed to unveil the therapeutic perspectives of this approach and pave the way for effective treatment of cartilage injuries in patients. © 2018 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res.

Original languageEnglish
Pages (from-to)12-22
Number of pages11
JournalJournal of Orthopaedic Research
Volume37
Issue number1
Early online date21 Sep 2018
DOIs
Publication statusPublished - 31 Jan 2019

Fingerprint

Chondrogenesis
Cartilage
Mesenchymal Stromal Cells
Investigational Therapies
Wounds and Injuries
Therapeutics
MicroRNAs
Chronic Pain
Hypertrophy
Cell Differentiation
Intercellular Signaling Peptides and Proteins
Transcription Factors
Transplantation
Economics
Morbidity
Delivery of Health Care
Research
Population

Keywords

  • cartilage repair
  • anti-chondrogenic factors
  • chondrogenesis
  • stem cells
  • MESENCHYMAL STEM-CELLS
  • CHONDROCYTE DIFFERENTIATION
  • NEGATIVE REGULATOR
  • IN-VITRO
  • ARTICULAR-CARTILAGE
  • GROWTH-FACTORS
  • EXTRACELLULAR-MATRIX
  • DIRECT INHIBITION
  • POTENTIAL ROLE
  • TRANSCRIPTION FACTOR

ASJC Scopus subject areas

  • Orthopedics and Sports Medicine

Cite this

Targeting anti-chondrogenic factors for the stimulation of chondrogenesis : A new paradigm in cartilage repair. / Lolli, Andrea; Colella, Fabio; De Bari, Cosimo; van Osch, Gerjo J V M (Corresponding Author).

In: Journal of Orthopaedic Research, Vol. 37, No. 1, 31.01.2019, p. 12-22.

Research output: Contribution to journalReview article

@article{fcc1d3e9aa2343e8868fb8b42358bda9,
title = "Targeting anti-chondrogenic factors for the stimulation of chondrogenesis: A new paradigm in cartilage repair",
abstract = "Trauma and age-related cartilage disorders represent a major global cause of morbidity, resulting in chronic pain and disability in patients. A lack of effective therapies, together with a rapidly aging population, creates an impressive clinical and economic burden on healthcare systems. In this scenario, experimental therapies based on transplantation or in situ stimulation of skeletal Mesenchymal Stem/progenitor Cells (MSCs) have raised great interest for cartilage repair. Nevertheless, the challenge of guiding MSC differentiation and preventing cartilage hypertrophy and calcification still needs to be overcome. While research has mostly focused on the stimulation of cartilage anabolism using growth factors, several issues remain unresolved prompting the field to search for novel solutions. Recently, inhibition of anti-chondrogenic regulators has emerged as an intriguing opportunity. Anti-chondrogenic regulators include extracellular proteins as well as intracellular transcription factors and microRNAs that act as potent inhibitors of pro-chondrogenic signals. Suppression of these inhibitors can enhance MSC chondrogenesis and production of cartilage matrix. We here review the current knowledge concerning different types of anti-chondrogenic regulators. We aim to highlight novel therapeutic targets for cartilage repair and discuss suitable tools for suppressing their anti-chondrogenic functions. Further effort is needed to unveil the therapeutic perspectives of this approach and pave the way for effective treatment of cartilage injuries in patients. {\circledC} 2018 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res.",
keywords = "cartilage repair, anti-chondrogenic factors, chondrogenesis, stem cells, MESENCHYMAL STEM-CELLS, CHONDROCYTE DIFFERENTIATION, NEGATIVE REGULATOR, IN-VITRO, ARTICULAR-CARTILAGE, GROWTH-FACTORS, EXTRACELLULAR-MATRIX, DIRECT INHIBITION, POTENTIAL ROLE, TRANSCRIPTION FACTOR",
author = "Andrea Lolli and Fabio Colella and {De Bari}, Cosimo and {van Osch}, {Gerjo J V M}",
note = "Funding Information: Marie Sklodowska Curie grant agreement. Grant Number: 642414",
year = "2019",
month = "1",
day = "31",
doi = "10.1002/jor.24136",
language = "English",
volume = "37",
pages = "12--22",
journal = "Journal of Orthopaedic Research",
issn = "0736-0266",
publisher = "John Wiley and Sons Inc.",
number = "1",

}

TY - JOUR

T1 - Targeting anti-chondrogenic factors for the stimulation of chondrogenesis

T2 - A new paradigm in cartilage repair

AU - Lolli, Andrea

AU - Colella, Fabio

AU - De Bari, Cosimo

AU - van Osch, Gerjo J V M

N1 - Funding Information: Marie Sklodowska Curie grant agreement. Grant Number: 642414

PY - 2019/1/31

Y1 - 2019/1/31

N2 - Trauma and age-related cartilage disorders represent a major global cause of morbidity, resulting in chronic pain and disability in patients. A lack of effective therapies, together with a rapidly aging population, creates an impressive clinical and economic burden on healthcare systems. In this scenario, experimental therapies based on transplantation or in situ stimulation of skeletal Mesenchymal Stem/progenitor Cells (MSCs) have raised great interest for cartilage repair. Nevertheless, the challenge of guiding MSC differentiation and preventing cartilage hypertrophy and calcification still needs to be overcome. While research has mostly focused on the stimulation of cartilage anabolism using growth factors, several issues remain unresolved prompting the field to search for novel solutions. Recently, inhibition of anti-chondrogenic regulators has emerged as an intriguing opportunity. Anti-chondrogenic regulators include extracellular proteins as well as intracellular transcription factors and microRNAs that act as potent inhibitors of pro-chondrogenic signals. Suppression of these inhibitors can enhance MSC chondrogenesis and production of cartilage matrix. We here review the current knowledge concerning different types of anti-chondrogenic regulators. We aim to highlight novel therapeutic targets for cartilage repair and discuss suitable tools for suppressing their anti-chondrogenic functions. Further effort is needed to unveil the therapeutic perspectives of this approach and pave the way for effective treatment of cartilage injuries in patients. © 2018 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res.

AB - Trauma and age-related cartilage disorders represent a major global cause of morbidity, resulting in chronic pain and disability in patients. A lack of effective therapies, together with a rapidly aging population, creates an impressive clinical and economic burden on healthcare systems. In this scenario, experimental therapies based on transplantation or in situ stimulation of skeletal Mesenchymal Stem/progenitor Cells (MSCs) have raised great interest for cartilage repair. Nevertheless, the challenge of guiding MSC differentiation and preventing cartilage hypertrophy and calcification still needs to be overcome. While research has mostly focused on the stimulation of cartilage anabolism using growth factors, several issues remain unresolved prompting the field to search for novel solutions. Recently, inhibition of anti-chondrogenic regulators has emerged as an intriguing opportunity. Anti-chondrogenic regulators include extracellular proteins as well as intracellular transcription factors and microRNAs that act as potent inhibitors of pro-chondrogenic signals. Suppression of these inhibitors can enhance MSC chondrogenesis and production of cartilage matrix. We here review the current knowledge concerning different types of anti-chondrogenic regulators. We aim to highlight novel therapeutic targets for cartilage repair and discuss suitable tools for suppressing their anti-chondrogenic functions. Further effort is needed to unveil the therapeutic perspectives of this approach and pave the way for effective treatment of cartilage injuries in patients. © 2018 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res.

KW - cartilage repair

KW - anti-chondrogenic factors

KW - chondrogenesis

KW - stem cells

KW - MESENCHYMAL STEM-CELLS

KW - CHONDROCYTE DIFFERENTIATION

KW - NEGATIVE REGULATOR

KW - IN-VITRO

KW - ARTICULAR-CARTILAGE

KW - GROWTH-FACTORS

KW - EXTRACELLULAR-MATRIX

KW - DIRECT INHIBITION

KW - POTENTIAL ROLE

KW - TRANSCRIPTION FACTOR

UR - http://www.scopus.com/inward/record.url?scp=85053686642&partnerID=8YFLogxK

UR - http://www.mendeley.com/research/targeting-antichondrogenic-factors-stimulation-chondrogenesis-new-paradigm-cartilage-repair

U2 - 10.1002/jor.24136

DO - 10.1002/jor.24136

M3 - Review article

VL - 37

SP - 12

EP - 22

JO - Journal of Orthopaedic Research

JF - Journal of Orthopaedic Research

SN - 0736-0266

IS - 1

ER -